Global private equity and venture capital news and research

Posts Tagged ‘Rock Springs Capital’

24 November 2015

Serious pregnancy condition drug developer nabs CHF60m VC-backed Series B

pregnant-244662_1920 Swiss biopharmaceutical company ObsEva, which develops drugs focusing on serious conditions compromising pregnancy, has raised a CHF60m ($59m) Series B round from a string of venture capital firms.

29 September 2015

Rock Springs leads $75m Series B round in Corvus Pharmaceuticals

research-853474_1280 Rock Springs Capital Management was lead investor in a $75m Series B financing round for US cancer treatment researcher Corvus Pharmaceuticals.

7 May 2015

VC-backed Adaptimmune eyes $175m net IPO proceeds after Nasdaq debut

blood-cells_sq Venture capital-backed biotech business Adaptimmune Therapeutics is eyeing net proceeds of about $175m from its IPO after pricing its shares at $17 each.

3 March 2015

Rock Springs, Sofinnova in cool $70m Series E for biopharma company Chiasma

syringe-m Venture capital investors Rock Springs Capital and Sofinnova Ventures have taken part in a sizable $70m funding round for US biopharmaceutical Chiasma.

26 August 2014

Sofinnova, Rock Springs in $55m Series C for Parkinson’s relief pharma company

luxurary-74895-m Sofinnova Ventures, Rock Springs Capital and Adage Capital Management are among new investors in a sizable $55m funding round for biopharmaceutical company Civitas Therapeutics.

29 May 2014

Sofinnova leads $72.8m Series B for Spark Therapeutics

medd Venture capital firm Sofinnova has led a massive $72.8m Series B round for gene therapy specialist Spark Therapeutics.

18 November 2013

TriVascular raises $40m Series E from new and existing investors

Medical devices startup TriVascular, which is focused on endovascular aortic repair, has raised a $40m Series E round.

Legals & Terms of UsePrivacy Policy

AltAssets is registered as a trademark of Investor Networks Limited (06695690).
Registered Office: Zetland House, 5-25 Scrutton St, London EC2A 4HJ
Content is © AltAssets 2000-2015